Donor leucocyte infusions for relapse in chronic myelogenous leukaemia
- 22 October 1994
- journal article
- Published by Elsevier in The Lancet
- Vol. 344 (8930) , 1101-1102
- https://doi.org/10.1016/s0140-6736(94)90624-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Leukemia: management of relapse after allogeneic bone marrow transplantation.Journal of Clinical Oncology, 1994
- Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid LeukemiaNew England Journal of Medicine, 1994
- Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation GroupBlood, 1993
- Interferon-α And Donor Buffy Coat Transfusions For Treatment Of Relapsed Chronic Myeloid Leukemia After Allogeneic Bone Marrow TransplantationTransplantation, 1993
- Graft-versus-leukemia: no longer an epiphenomenon [editorial]Blood, 1993
- Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell doseBlood, 1993
- Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.Journal of Clinical Oncology, 1993
- Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation [letter]Blood, 1992
- Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patientsBlood, 1990